ATTO
Atento SA
NASDAQ · Healthcare · Biotechnology · US
$22.14
−2.60%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 561.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.96x
- Price / sales
- 748.68x
- Price / cash flow
- -17.07x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 857.88x
- EV / EBITDA
- -17.45x
- EV / EBIT
- -17.24x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026